A Clinical Manifesto on SGLT2 Inhibitors in Patients With Heart Failure
Published: 25 August 2020
-
Views:
26
-
Likes:
7
-
Views:
26
-
Likes:
7
Overview
This educational symposium was part of the eSPACE Heart Failure meeting held 11-14 July 2020.
The session focuses on latest data and practical implication of SGLT2 Inhibitors in Heart Failure patients.
Learning objectives
- Encourage conversation around SGLT2 inhibitors as cardiovascular therapies with cardio–renal benefits
- Highlight and discuss profiles of appropriate patients for initiation of an SGLT2 inhibitor, and share with cardiologists the well-established safety profile of and the clinical considerations for treatment with an SGLT2 inhibitor
- Inform cardiologists of the current evidence and ongoing trials for SGLT2 inhibitors in patients with heart failure
Symposium Agenda
Time - Session title and objective - Speaker(s)
- 25 mins - Health: SGLT2 inhibitors and quality of life - Martin Cowie, Shelley Zieroth
- 5 mins - Transition
- 25 mins - Protect: SGLT2 inhibitors in patients with HF - Martin Cowie, Nikolaus Marx
- 5 mins - Transition
- 25 mins - Wealth: An abundance (and more to come) of SGLT2 inhibitor evidence - Stefan Anker, Andrew Coats
- 5 mins - Close
More from this programme
Part 1
Welcome & Introductions
| 1 session | |
| Welcome & Introductions | Watch now |
Part 2
Health: SGLT2 Inhibitors and Quality of Life
Part 3
Protect: SGLT2 Inhibitors in Patients with HF
Part 4
Wealth: An Abundance (and More to Come) of SGLT2 Inhibitor Evidence
Part 5
Panel Discussion
| 1 session | |
| Panel Discussion | Watch now |
Faculty Biographies
Martin R Cowie
Dr Martin R Cowie is Professor of Cardiology at the National Heart and Lung Institute, Imperial College and Honorary Consultant Cardiologist at the Royal Brompton Hospital, London.
Dr Cowie currently chairs the Clinical Practice Committee of the British Cardiac Society and sits on the UK Department of Health’s Primary Care and Heart Failure Implementation Board. He was the clinical advisor for the recently published National Institute for Clinical Excellence (NICE) guideline on the management of chronic heart failure and is a member of the Clinical Effectiveness Forum of the Royal College of Physicians. He has just completed a term of office on the Clinical Guidelines Committee of the European Society of Cardiology.
Dr Cowie’s studies and reviews have been featured in a variety of peer-reviewed journals, including The Lancet, European Heart Journal, British Medical Journal, Heart and the International Journal of Cardiology. He is a member of the…